Table 2 Summary of QD-based biosensing platforms, including sensing nanostructures, target analytes, sensing mechanisms, LOD, and corresponding linear detection ranges reported in the literature
From: Quantum dot biosensors for highly sensitive and multiplex detection in biomedical diagnostics
Sensing nanostructure/platform | Target Analyte | Sensor type | LOD | Linear range | Ref. |
|---|---|---|---|---|---|
CdTeS QDs@SiO₂ + ZnCdS QDs@MIP | Ascorbic acid | Ratiometric fluorescence | 0.78 µM | 1–500 µM | [61] |
GONAP + Ab–QDs complexes | Human IgG ; E. coli | Wash-free, single-antibody photoluminescent immunosensor | For E. coli: 65 CFU g− 1 (poultry), and 70 CFU mL− 1 (river water). For human IgG : 1.60 ng mL− 1 | – | [62] |
CdTe QDs conjugated with rabbit anti-AIV H5N1 antibody | AIV H5N1 antigen | sFLISA | 1.5 × 10⁻⁴ µg mL⁻¹ | 8.0 × 10⁻³ - 5.1 × 10⁻¹ µg mL⁻¹ | [63] |
QD-dsDNA | HIV-DNA | Fluorescent lateral flow assay (QD-based ICA strip) | 0.76 pM | 1 pM - 10 nM | [64] |
Quantum fluorescent dots (used in immunochromatographic strip) | SARS-CoV-2 (S-gene fragment) | CRISPR/Cas13a-assisted fluorescent immunochromatographic assay | 1 virus mL− 1 | – | [65] |
QD/MS/MIP | Tetracycline | Fluorescence probe (MIP-based) | – | 50–1000 ng mL⁻¹ | [66] |
CuInSe₂ (CISe) QDs coated with ZnS shell (CISe@ZnS) | CTCs | NIR-II luminescent bioassay / imaging nanoprobe | 12 cells well− 1 | – | [68] |
HM-Fe₃O₄@SiO₂/Tetra-DNA-Ag₂S | CTCs | NIR fluorescence-based magnetic separation nanoplatform | – | 6–10 cells mL⁻¹ (patient blood samples) | [69] |
TiO₂/CdS nanosheets with Ag@Cu₂O core-shell submicron particles (SPs) | cTnI | PEC | 6.7 fg mL− 1 | 0.02 pg mL− 1 - 50 ng mL− 1 | [74] |
RGO–AuNPs with CdTe QDs | CEA | PEC aptasensor | 0.47 pg mL− 1 | 0.001–2.0 ng mL− 1 | [75] |
CuInS₂ microflowers (MFs) with Ce6-Ab2-PAA@UCNPs | Prostate-specific antigen (PSA) | PEC + NIR-FV immunosensor | 0.03 pg mL− 1 (PEC mode) | PEC: 0.0001–50 ng mL− 1; NIR-FV: 0.001–10 ng mL− 1 | [76] |
Co²⁺-doped CdTe nanocrystals | CEA | NIR ECL immunosensor | 0.2 fg mL− 1 | 1 fg mL− 1 – 10 pg mL− 1 | [85] |
CdS: Mn QDs with AuNPs using DCHA | miRNA-21 and MUC1 | ECL | miRNA-21: 11 aM; MUC1: 0.40 fg mL− 1 | – | [86] |
SQDs with tsDNA nanostructures | miRNA-21 | NIR ECL biosensor | 6.67 aM | 20 aM - 1 nM | [87] |
Luminol/CQDs/CdS QD–AuNP–MB ECL nanoprobes | IFN-γ, TNF-α, IL-2 (triple LTBI markers) | Multiplexed ECL immunosensor | – | 1.6–200 pg mL− 1 | [88] |
Micelles co-encapsulating hydrophobic CdSe/ZnS QDs + dibenzoyl peroxide (coreactant) | SARS-CoV-2 nucleocapsid Protein | ECL Immunosensor | 3.0 pg mL− 1 | 0.01 -50 ng mL− 1 | [89] |